Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

A review of the current status of siRNA nanomedicines in the treatment of cancer.

Abstract :

RNA interference currently offers new opportunities for gene therapy by the specific extinction of targeted gene(s) in cancer diseases. However, the main challenge for nucleic acid delivery still remains its efficacy through intravenous administration. Over the last decade, many delivery systems have been developed and optimized to encapsulate siRNA and to specifically promote their delivery into tumor cells and improve their pharmacokinetics for anti-cancer purposes. This review aims to sum up the potential targets in numerous pathways and the properties of recently optimized siRNA synthetic nanomedicines with their preclinical applications and efficacy. Future perspectives in cancer treatment are discussed including promising concomitant treatment with chemotherapies or other siRNA. The outcomes in human clinical trials are also presented.

Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.univ-angers.fr/hal-03178911
Contributeur : Okina Université d'Angers <>
Soumis le : mercredi 24 mars 2021 - 09:50:11
Dernière modification le : jeudi 10 juin 2021 - 17:07:08
Archivage à long terme le : : vendredi 25 juin 2021 - 18:21:16

Fichier

resnier_2013_a_review_of_the_c...
Accord explicite pour ce dépôt

Identifiants

Citation

Pauline Resnier, Tristan Montier, Véronique Mathieu, Jean-Pierre Benoit, Catherine Passirani-Malleret. A review of the current status of siRNA nanomedicines in the treatment of cancer.. Biomaterials, Elsevier, 2013, 34 (27), pp.6429-43. ⟨10.1016/j.biomaterials.2013.04.060⟩. ⟨hal-03178911⟩

Partager

Métriques

Consultations de la notice

125

Téléchargements de fichiers

111